Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
and science to thrive. PhD position - Modelling plant-microbe interactions Our goal: Advance our understanding of plant–microbe communication to support the development of more resilient crops. Your
-
. Flexible working hours, a home office allowance, and hybrid working options. Freedom and support to shape your own research path. A strong academic community and access to professional development through
-
multimodal approaches combining TMS and TES with neuroimaging and neurophysiology as well as expanding closed-loop approaches to NIBS. Our group pioneered the development of simultaneously implemented TMS-fMRI
-
located at Brightlands Chemelot Campus in Geleen. You will become part of a young international research group, specialized in plasma catalysis. The development of innovative and green chemical processes is
-
international research group, specialized in plasma catalysis. The development of innovative and green chemical processes is essential for transitioning to a carbon-neutral and energy-efficient society. Methane
-
sources including Italian or Turkish language, as relevant; Archival research and oral history focused on the experiences of women migrants; Participating in the development of a counter-archive of migrant
-
). Your research will be embedded in a dynamic and supportive environment, where you will have ample opportunities for professional development, scientific exchange, and collaboration with both academic and
-
also offer to our students. Last but certainly not least, we provide the space and facilities for your personal and professional development. We facilitate this by offering a wide range of training
-
will contribute to the development of experimental designs, run behavioral experiments and collect and analyze intracranial EEG data which provide a unique opportunity to get direct access to hippocampal
-
that makes our education and research possible. Two Postdoctoral research positions on the development of cell delivery-based beta cell replacement therapy for the treatment of type 1 diabetes The positions